Publications by authors named "George Emile"

Claim this Profile
L
Links between nocturnal hypoxia and cognitive function in breast cancer.
Clara Elia, Joy Perrier, Mylène Duivon, Stéphane Rehel, François Gernier, George Emile

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.
Zoé Neviere, Cécile Blanc-Fournier, Anne-Valérie Guizard, Nicolas Elie, Florence Giffard, George Emile

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and early F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy.
Charline Lasnon, Adeline Morel, Nicolas Aide, Angélique Da Silva, George Emile

Cancer Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.
François-Clément Bidard, Nicolas Kiavue, William Jacot, Thomas Bachelot, Sylvain Dureau, George Emile

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
Angéline Galvin, Coralie Courtinard, Fanny Bouteiller, Sophie Gourgou, Florence Dalenc, George Emile

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Fanny Le Du, Matthieu Carton, Thomas Bachelot, Mahasti Saghatchian, Barbara Pistilli, George Emile

Oncologist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
Jordane Divoux, Romane Florent, Margaux Jacobs, Justine Lequesne, Jean-Michel Grellard, George Emile

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
François Gernier, Jean-Michel Grellard, Charlotte Dupont, Hervé Castel, Marie Fernette, George Emile

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
Pauline Rottier, George Emile, Alison Johnson, Christelle Levy, Djelila Allouache

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics to select treatment for patients with metastatic breast cancer.
Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, George Emile

Nature· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
François Cherifi, Angélique Da Silva, Alison Johnson, Cécile Blanc-Fournier, Olivia Abramovici, George Emile

BMC Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Ombline de Calbiac, Amélie Lusque, Audrey Mailliez, Thomas Bachelot, Lionel Uwer, George Emile

JAMA Netw Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task.
Mylène Duivon, Joy Perrier, Carine Segura-Djezzar, Florence Joly, Stéphane Rehel, George Emile

Front Neurosci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort.
Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, George Emile

Breast· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rest activity rhythms characteristics of breast cancer women following endocrine therapy.
Tristan Martin, Mylène Duivon, Nicolas Bessot, Jean-Michel Grellard, George Emile

Sleep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib.
George Emile, Sarah Penager, Christelle Levy, Alison Johnson, Djelila Allouache

Oncol Lett· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on overall survival in patients with metastatic breast cancer.
Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, George Emile

Breast· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
François-Clément Bidard, William Jacot, Nicolas Kiavue, Sylvain Dureau, Amir Kadi, George Emile

JAMA Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.
Anne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, Alain Lortholary, Benoît You, George Emile

Breast· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib-induced reversible grade 4 nephrotoxicity.
Angélique Da Silva, Basile Chretien, Joachim Alexandre, George Emile

Breast J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration.
Angelique DA Silva, Christelle Levy, Djelila Allouache, Ioana Hrab, Adeline Morel, George Emile

Anticancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Florian Clatot, Anne Perdrix, Ludivine Beaussire, Justine Lequesne, Christelle Lévy, George Emile

Breast Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian Carcinoma.
Guillaume Beinse, George Emile, Anatole Cessot, Pascaline Boudou-Rouquette, Olivier Huillard

Int J Gynecol Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.
Frédéric Selle, George Emile, Patricia Pautier, Irène Asmane, Daniele G Soares

Oncol Lett· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters.
Zahra Ajgal, Nicolas Chapuis, George Emile, Anatole Cessot, Jean Marie Tigaud

Cancer Chemother Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis